Helen G. Haggerty

Task force report: Future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions

N. Franklin Adkinson, David M. Essayan, Rebecca S. Gruchalla et al. · Journal of Allergy and Clinical Immunology · 2002 · 87 citations

Drug Hypersensitivity, Allergy, Allergy Medicine +9

Abatacept treatment does not exacerbate chronic <i>Mycobacterium tuberculosis</i> infection in mice

Carolyn Bigbee, Daryl G. Gonchoroff, George Vratsanos et al. · Arthritis & Rheumatism · 2007 · 77 citations

Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis.

Helen G. Haggerty, Mark A. Abbott, Timothy P. Reilly et al. · PubMed · 2007 · 59 citations

Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy

Clay B. Siegall, Helen G. Haggerty, Garvin L. Warner et al. · The Journal of Immunology · 1997 · 35 citations

Nonclinical Aspects of Biopharmaceutical Development: Discussion of Case Studies at a PhRMA-FDA Workshop

Lorrene A. Buckley, K. A. Benson, Karen Davis‐Bruno et al. · International Journal of Toxicology · 2008 · 28 citations

Nonclinical Aspects, Phrma-fda Workshop, Pathology +16